Niepubliczny Zaklad Opieki Zdrowotnej Euromedica Sp. z o.o.
- Address
- lock Available on a paid plan
Nutritional and Metabolic Diseases
At Niepubliczny Zaklad Opieki Zdrowotnej Euromedica Sp. z o.o. in Grudziadz, clinical research in Nutritional and Metabolic Diseases focuses on common conditions such as obesity and type 2 diabetes. These studies are designed to evaluate new treatment approaches that may improve blood sugar control and support better long-term management of metabolic health.
- Type 2 Diabetes inadequately controlled with dapagliflozin with or without metformin
- Obesity and related cardiovascular risk
- Testing therapies to improve HbA1c and overall treatment effectiveness
The work reflects a practical focus on helping patients whose diabetes or weight-related conditions remain difficult to control with standard care.
Psychiatry and Psychology
The site also supports research in Psychiatry and Psychology, especially for major depressive disorder and major depressive disorder with moderate-to-severe anhedonia. These trials explore new ways to prevent relapse, improve symptom control, and assess the longer-term safety of add-on treatments for people living with depression.
- Major Depressive Disorder with anhedonia
- Preventing relapse of depressive symptoms after initial response
- Evaluating the safety and tolerability of adjunctive mental health therapies
This area of research aims to strengthen treatment options for patients who need additional support beyond standard antidepressant therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Niepubliczny Zaklad Opieki Zdrowotnej Euromedica Sp. z o.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD | Boehringer Ingelheim Espana S.A., Boehringer Ingelheim International GmbH, Boehringer Ingelheim RCV GmbH & Co. KG | Phase III | Not Recruiting | Jan 2024 | Jun 2026 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aticaprant | 1 | Unknown | 2024-12-04 | 2024-12-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.